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β-lactamases are the primary cause of resistance to β-lactams among members of the
family Enterobacteriaceae. SHV enzymes have emerged in Enterobacteriaceae causing
infections in health care in the last decades of the Twentieth century, and they are
now observed in isolates in different epidemiological settings both in human, animal
and the environment. Likely originated from a chromosomal penicillinase of Klebsiella
pneumoniae, SHV β-lactamases currently encompass a large number of allelic variants
including extended-spectrum β-lactamases (ESBL), non-ESBL and several not classified
variants. SHV enzymes have evolved from a narrow- to an extended-spectrum of
hydrolyzing activity, including monobactams and carbapenems, as a result of amino
acid changes that altered the configuration around the active site of the β -lactamases.
SHV-ESBLs are usually encoded by self-transmissible plasmids that frequently carry
resistance genes to other drug classes and have become widespread throughout the
world in several Enterobacteriaceae, emphasizing their clinical significance.
Keywords: β-lactamase, ESBL, blaSHV, SHV-2, SHV-5, SHV-12, plasmid, Enterobacteriaceae
INTRODUCTION
Thanks to their ability to inhibit cell wall biosynthesis, β-lactams remained the first-line defense
against bacterial infections for over 20 years, before resistant bacteria appeared in clinical practice.
Resistance to this class of drugs can be the result of antibiotic target site alteration, prevention
of antibiotic access by altered permeability or forced eﬄux, or antibiotic degradation (Wilke
et al., 2005). The latter, represents the primary resistance mechanism in Gram-negative bacteria
producing β-lactamase enzymes able to covalently bind the carbonyl moiety of the β-lactam ring
and hydrolyze its amide bond (Fisher et al., 2005). Naturally occurring chromosomally located β-
lactamases are quite common in Gram-negative bacteria; likely evolved from penicillin-binding
proteins, when produced in small quantity they do not significantly contribute to antibiotic
resistance. It was the appearance of the first plasmid-mediated β-lactamase TEM-1 (Datta and
Kontomichalou, 1965) to designate the beginning of an unstoppable phenomenon in the 1960s.
Ever since, the introduction of new natural or synthetic drugs to replace old ones in an attempt to
limit the insurgence of antibiotic resistant bacteria triggered a chain reaction providing bacteria
with a constant selective pressure driving the expansion of different resistance mechanisms
(Medeiros, 1997).
In recent years β-lactamases have extensively diversified in response to the clinical use of new
generations of β-lactams (penicillin, cephalosporins, carbapenems, and monobactams) leading
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to the need of classification schemes. Based on primary structure
(Ambler, 1980), enzymatic properties and biochemical attributes
(Bush et al., 1995), and the increasingly available amino acid
sequences (Bush and Jacoby, 2010) four major classes (A, B, C, D)
can be acknowledged. Serine β-lactamases belonging to class A
are the most abundant (Philippon et al., 2016), with more than
500 enzymes, including the most clinically significant extended
spectrum β-lactamases (ESBL) variants, i.e., CTX-M-, TEM-, and
SHV-type enzymes (Bush and Fisher, 2011).
Although, SHV enzymes did not undergo the explosive
dissemination observed for CTX-M-type variants (Canton
et al., 2012), in recent years they have been found in several
Enterobacteriaceae outside of the typical clinical hosts Klebsiella
pneumoniae and Escherichia coli, with a rising allele variability
(http://www.lahey.org/studies), and in different environmental
niches. Many admirable works describing the biochemistry, the
genetics and the evolution of SHV β-lactamases have appeared
over the last years. The aim of this review is to provide the readers
with an updated overview on SHV β-lactamases, their amino acid
variants and spectrum of activity, and to describe the occurrence
of plasmid-associated SHV enzymes in Enterobacteriaceae and
their epidemiological significance.
ORIGIN AND DIVERSITY OF THE SHV
FAMILY
The first blaSHV-1 gene was identified in the 1970s in E.
coli (Pitton, 1972). The encoded enzyme SHV−1 (sulfhydryl
reagent variable) proved its activity against penicillins and
first generation cephalosporins (Matthew et al., 1979) and was
confirmed part of the conjugative plasmid p453 (Barthélémy
et al., 1988; Table 1). The most likely ancestor of the
plasmid-mediated SHV−1 is a chromosomal species-specific
penicillinase detected in fecal K. pneumoniae isolates from
neonates (Haeggman et al., 1997). The enzyme showed a typical
antibiogram with penicillin rather than cephalosporin resistance
and a marked inhibition by clavulanic acid. How blaSHV-1 moved
from the chromosome to the plasmid does not have a conclusive
explanation since the proposed association with a transposable
element (Nugent and Hedges, 1979) has not been confirmed.
As of today, 1891 SHV allelic variants have been
described, having developed resistance to 3rd generation
cephalosporin (Tzouvelekis and Bonomo, 1999), monobactam
and carbapenems (Poirel et al., 2003). Only a small proportion
is biochemically and/or genetically characterized (http://www.
lahey.org/studies). SHV β-lactamases can be divided into three
subgroups on the basis of molecular characteristics or functional
properties: (i) subgroup 2b (n = 37), able to hydrolyze penicillins
and early cephalosporins (cephaloridine and cephalothin) and
strongly inhibited by clavulanic acid and tazobactam; (ii)
subgroup 2br (n = 7), broad-spectrum β-lactamases that
acquired resistance to clavulanic acid; and (iii) subgroup 2be
(n = 46), comprises ESBLs that can also hydrolyze one or more
oxyimino β-lactams (cefotaxime, ceftazidime, and aztreonam).
1Of the 194 variants available on line (http://www.lahey.org/studies), 5 were
withdrawn or invalidated as only partial sequence.
More than half of these variants (n = 99) has not been classified
yet due to absence of biochemical characterization.
Figure 1 illustrates a phylogenetic analysis of 149 out of
the 189 SHV β-lactamase variants whose amino acid sequences
were available online (http://www.lahey.org/studies), as of July
2016. Unlike other β-lactamase families (D’andrea et al., 2013;
Evans and Amyes, 2014), there is no clear clustering of the
different subgroups, as also mirrored by gene based analysis
(Supplementary Figure S1). Among the majority of unclassified
variants, subgroup 2b and the few 2br variants are scattered
all over the tree. Subgroup 2be showed clustering of most of
the ESBL variants (including SHV-2a, SHV-5, and SHV-12),
together with few non-classified enzymes (SHV−29, SHV−152,
SHV−153, SHV−160, and SHV−165). It has been proposed
that SHV β-lactamases descended from an unidentified ancestor
holding an extended spectrum phenotype (2be) and that
subgroup 2b derived from it (Hall and Barlow, 2004). Our
analysis showed that several of SHV ESBL variants were scattered
along the tree with short branch lengths with neighboring 2b
or unknown variants within the SHV phylogeny (i.e., SHV−40,
SHV−11, and SHV−35; Figure 1), supporting the hypothesis
that they evolved from multiple variants, probably within
the antibiotic era. Among the non-ESBL variants, blaSHV-11
represents one of themost successful and, together with blaSHV-1,
the likely source of evolution for the existing SHV ESBL variants.
blaSHV-11 was first identified as plasmid-encoded in clinical K.
pneumoniae from Switzerland (Nüesch-Inderbinen et al., 1997)
and ever since has been isolated worldwide.
Although, nearly displaced, together with TEM, by CTX-M
enzymes over the years (Canton et al., 2012), 46 ESBL blaSHV
genes have been described so far (Table 1). The first report
of SHV-mediated resistance to third-generation cephalosporins
was in 1983 with the isolation and characterization of blaSHV-2,
encoded by plasmid pBP60 in a German clinical isolate of
Klebsiella ozaenae and showing only a few nucleotide mismatches
with blaSHV-1 (Kliebe et al., 1985). In a few years four other
ESBL variants were identified as plasmid-encoded in clinical
K. pneumoniae, showing variable gene homologies with the
blaSHV-1 and blaSHV-2 sequences (50–90%): blaSHV-2a encoded
by conjugative plasmid pZMP1 (Podbielski et al., 1991); blaSHV-3
on pUD18 (Nicolas et al., 1989); blaSHV-4, widely disseminated
from France as a result of a single K. pneumoniae clone
diffusion (Arlet et al., 1990, 1994); and blaSHV-5 able to hydrolyze
broad-spectrum cephalosporins and monobactams (Gutmann
et al., 1989). Of these first variants, the most epidemiologically
successful were blaSHV-2a and blaSHV-5, which will be further
discussed, together with blaSHV-2 and blaSHV-12, in a dedicated
paragraph (Section Expansion toward New Ecological Niches).
Interestingly, blaSHV-3 and blaSHV-4 have been only sporadically
detected since their first description. blaSHV-3 seems to be
geographically restricted to the USA where it was detected
in E. coli of animal origin, associated with other antibiotic
resistance genes such as blaCTX-M-15, blaCTX-M-24, blaCMY-2,
and/or blaTEM-1 (Shaheen et al., 2011). blaSHV-4 was identified
also in Enterobacter aerogenes and Citrobacter diversus in
different countries (Arpin et al., 1996; El Harrif-Heraud et al.,
1997; Pitout et al., 1998).
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FIGURE 1 | Maximum likelihood amino acid tree of 149 SHV-type β-lactamases. Variants whose sequence has not been released in GenBank as of July 2016,
that show partial sequence or are identical to others (http://www.lahey.org/studies/) were not included in the analysis. SHV-180 and SHV-181 share the same
sequence as well as SHV-121 and SHV-136. The tree was implemented in Mega version 6.06 (Tamura et al., 2013). Solid circles represent: red, extended-spectrum
β-lactamases (2be; n = 46); green, broad-spectrum β-lactamases (2br, n = 5); and blue, penicillinases (2b, n = 30). Unclassified alleles are reported in black (n = 68).
The last two decades witnessed the appearance of several
new variants (blaSHV-7, blaSHV-8, blaSHV-9, blaSHV-31, blaSHV-38,
blaSHV-40, blaSHV-41, and blaSHV-42) whose dissemination was
restricted to limited cases (Supplementary Table S1). A few
variants seem to be geographically constrained: (i) blaSHV-106,
only described in Portuguese isolates of K. pneumoniae together
with blaTEM-1, and/or blaCTX-M-32 (Mendonça et al., 2009);
(ii) blaSHV-55, in Portugal (Mendonça et al., 2006; Machado
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et al., 2007) and recently in Brazil (Dropa et al., 2015); and
(iii) blaSHV-57, in E. coli isolates from Taiwan and China (Ma
et al., 2005; Tian et al., 2012). A variant worth to mention
is blaSHV-27 (Corkill et al., 2001), that has been detected on
different plasmids in E. coli, K. pneumoniae and Enterobacter
cloacae, associated with a vast array of antibiotic resistance genes
(blaDHA−1, blaTEM-1, blaTEM−1b, blaCMY-2, blaIMP, blaCTX-M-14,
blaCTX-M-15, blaSHV-12, blaSHV-45, blaOXA-1, dfrA5, ereA2;
Muratani et al., 2006; Abbassi et al., 2008; Kiratisin et al., 2008;
Duval et al., 2009; Hammami et al., 2011).
Most of SHV ESBLs (25 out of 46) are unique cases, with
only one report so far. Seventeen variants are exclusively
found in clinical K. pneumoniae: blaSHV-6, blaSHV-13,
blaSHV-16, blaSHV-18, blaSHV-23, blaSHV-45, blaSHV-64,blaSHV-66,
blaSHV-86, blaSHV-90, blaSHV-91, blaSHV-98, blaSHV-99,
blaSHV-100,blaSHV−104,blaSHV-105, and blaSHV-134. These variants
have been described worldwide (Brazil, Portugal, Algeria, USA,
Tunisia, Netherlands, France, South Africa, Colombia, and
China) and are mostly associated to plasmids (Table 1). Some of
these variants are sporadically accompanied by other antibiotic
resistance genes like in the case of: (i) blaSHV-45 encoded by
an IncA/C plasmid together with blaCTX-M-2 and blaSHV-27
(Dropa et al., 2015); (ii) blaSHV-134 encoded by an IncFII
plasmid accompanied by a second plasmid carrying blaVIM−1
(Sánchez-Romero et al., 2012); (iii) and blaSHV-105, conferring
reduced susceptibility to ceftazidime, ceftriaxone, and aztreonam
together with blaSHV-1, and blaSHV-5 (Jones et al., 2009). One
of the oldest variants, blaSHV-6, was only described in France in
1991 in a K. pneumoniae clinical case (Arlet et al., 1991). It might
be speculated that the 180 kb plasmid encoding blaSHV-6 and
conferring decreased susceptibility to ceftazidime and aztreonam
was not stable or it reduced bacterial strain fitness preventing a
successful dissemination.
Four variants have been described only in clinical E. coli: (i)
blaSHV-15, described together with blaCMY-2 in a strain imported
from India into the United Kingdom (http://www.lahey.org/
studies/); (ii) blaSHV-24, identified in Japan on a transferable
150Kb plasmid conferring high-level resistance to ceftazidime
but not cefotaxime and cefazolin (Kurokawa et al., 2000);
emergence of SHV-24 might have been driven by the extensive
use of ceftazidime in Japan, enabling bacterial survival in high
concentrations of this drug; (iii) blaSHV-102, recovered in a
Spanish hospital and hydrolyzing cefotaxime and ceftazidime
(Vinué et al., 2008); (iv) and blaSHV-129, detected in an abscess
specimen from a patient hospitalized in Italy in 2008 (Lascols
et al., 2012).
blaSHV-46 was only described on a 70Kb conjugative plasmid
also carrying blaTEM-1 and blaKPC−2 in a carbapenem-resistant
strain of Klebsiella oxytoca from the urine of a hospitalized
patient in New York (USA) in 1998 (Yigit et al., 2003).
Finally, blaSHV-34 is an interesting example of extended-spectrum
β-lactamase encoded by an epidemic plasmid circulating
among Citrobacter koseri, E. coli, and K. pneumoniae in the
same US hospital between 1998 and 2000 (Heritage et al.,
2003).
Majority of SHV ESBLs have been detected in K. pneumoniae
or E. coli (Table 1). blaSHV-30 was the first variant to be detected
in an E. cloacae isolate from a blood culture from a solid-organ
transplant recipient in the USA in 2003 (Szabó et al., 2005).
The gene, previously described in K. pneumoniae and Salmonella
(Mulvey et al., 2004; Whichard et al., 2007), was located on
a 9.4 Kb plasmid and contributed together with chromosomal
ampC, blaSHV-7, and blaTEM-1 to the antibiotic resistance profile
of the E. cloacae isolate, the first of its kind producing two
different SHV enzymes. Three other novel ESBL variants have
been solely identified as plasmid-encoded in clinical E. cloacae:
(i) blaSHV-70, from a Chinese patient with history of ceftazidime
treatment (Ling et al., 2006) and observed in other clinical
Chinese settings (Liu et al., 2008); (ii) blaSHV-128, isolated in
Tunisia in 2009, located on an IncFII conjugative plasmid, and
conferring resistance to all β-lactams except imipenem (Bourouis
et al., 2015); (iii) and blaSHV-183, for which additional description




Extended-spectrum SHV β-lactamases belong to functional
group 2be, while very recently they were assigned to subclass
A1 of serine β-lactamases, clustering with TEM and CTX-M
enzymes among other clinically relevant β-lactamases (Bush,
2013; Philippon et al., 2016). SHV ESBLs consist of two
subdomains: an α/β that includes an antiparallel five-stranded
β-sheet flanked by α-helices, and an all-α-helical subdomain
(Matagne et al., 1998). Similar to TEM β-lactamases (Jelsch et al.,
1993), the active site is located within the cleft created by the
subdomains and it contains the Ser70 residue that mediates the
nucleophilic attack on the carbonyl group of the β-lactam ring.
In the vicinity of this serine residue, several conserved structural
and functional amino acid motifs have been identified. These
include the Ser70XXLys (“SXXK” motif, with X representing
variable amino acids), the Ser130AspAsn (“SDN” motif), the
Glu166XXLysAsn (“EXXLN” motif), and the Lys234Thr/SerGly
(“KTG” motif) (Bush, 2013).
Each SHV ESBL has one (SHV-2, SHV-6, SHV-8, SHV-24,
SHV-27, SHV-38, SHV-41, SHV-57, SHV-98, SHV-99, SHV-102,
and SHV-104) to six (SHV-128) amino acid substitutions when
compared to SHV-1 (Table 2), indicating that even a single amino
acid substitution is enough to convey an extended-spectrum
phenotype. Therefore, we can speculate that other SHV ESBLs
may still evolve from a parental SHV β-lactamase due to single
spectrum-extending substitutions, although the majority of them
have possibly emerged through a stepwise acquisition of several
mutations (substitutions, deletions and/or insertions) from pre-
existing extended-spectrum SHV variants.
Among SHV ESBLs, amino acid substitutions are
predominantly located at positions Leu35, Gly238, and Glu240,
while other less frequent but critical substitutions for the
extended-spectrum phenotype occur on several amino acids
including Ile8, Arg43, Glu64, Gly156, Asp179, and Arg205 (Table 2).
Although, most of these residues are not involved directly in β-
lactams hydrolysis, they result in the enhancement or relaxation
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of the active site, enabling it to accommodate and to efficiently
react with oxyimino-β-lactams (Tzouvelekis and Bonomo, 1999).
Amino acid substitutions on some of these positions (Arg43,
Asp179, Arg205, Gly238, and Glu240) have been also associated
with the expansion toward an ESBL phenotype among TEM
enzymes (Knox, 1995).
Residue Leu35 is located further away from the active site of
class A β-lactamases and its substitution to Gln (e.g., SHV-2a,
SHV-12) has been suggested to have an indirect role in enhancing
the extended-spectrum capability of SHV β-lactamases (Nüesch-
Inderbinen et al., 1997). In contrast, Gly238 and Glu240 amino
acids are part of the active site lying near the R1 side chain
of the β-lactam (Huletsky et al., 1993). Substitutions in Gly238
either to Ser (e.g., SHV-2, SHV-2a) or Ala (e.g., SHV-13, SHV-
18) displace the β3-strand from the reactive Ser70, resulting
in a slightly expanded active site. This conformational change
improves the binding to and the accommodation of newer
cephalosporins with large C7 substituents, thereby expanding the
substrate spectrum of these SHV ESBLs to include cefotaxime
and to a lesser extent to ceftazidime (Huletsky et al., 1993;
Matagne et al., 1998; Nukaga et al., 2003). It has been suggested
that Glu240 substitutions to Arg (SHV-86) or Lys (e.g., SHV-4,
SHV-5) cause the ammonium group of the long side-chains of
these residues to form an electrostatic bond with the carboxylic
acid group on the oxyimino-substituents of ceftazidime and
aztreonam (Knox, 1995). This interaction has a dual effect
on the hydrolysis of ceftazidime by improving initial binding
and facilitating proper positioning within the SHV β-lactamase,
whereas the hydrolysis of other β-lactams is less affected
(Huletsky et al., 1993). Gly238Ser and Glu240Lys amino acid
substitutions characterize the majority of SHV ESBLs (Table 2)
and mirror those seen in extended-spectrum TEM β-lactamases.
Interestingly, a plethora of extended-spectrum SHV and TEM
β-lactamases exhibit higher levels of hydrolytic activity against
ceftazidime than against cefotaxime (ceftazidimases) (Table 3).
This phenotype was attributed to the Glu240Lys substitution,
in contrast with most CTX-M β-lactamases lacking this critical
substitution and only showing a cefotaximase activity, (Bonnet,
2004).
Among the less frequent but critical substitutions, Ile8Phe
in the signal sequence of the precursor of SHV ESBLs (e.g.,
SHV-7, SHV-18) has been associated with a more efficient β-
lactamase transfer into the periplasm (Randegger et al., 2000),
a proof that, beside enzymatic structure and gene expression,
also the rate of transfer plays a role in resistance phenotype.
On the contrary, Arg43Ser (e.g., SHV-7, SHV-18) and Gly156Asp
(SHV-27, SHV-45, SHV-105) substitutions affect the structural
arrangement of the conserved residues 64–69 and 166–170,
respectively. These changes, opposite to the active site cavity
(Ser70) for the hydrolysis of the β-lactam molecules, expand the
active site to accommodate bulkier cephalosporins (Knox, 1995;
Corkill et al., 2001). Asp179 amino acid is highly conserved among
subclass A1 of serine β-lactamases and together with Arg164 form
a salt bridge that links the two ends of the  loop. Substitutions
Asp179Ala (SHV-6), Asp179Asn (SHV-8) and Asp179Gly (SHV-
24) result in the elimination of the salt bridge with subsequent
increase in ceftazidime resistance (Sowek et al., 1991). Several
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other amino acid substitutions (Table 2) have been described
as either responsible for or possibly contributing to the ESBL
phenotype, the detailed description of which exceeds the scope
of this review.
Apart from point mutations leading to amino acid
substitutions, frame shift mutations have been observed
with very low occurrence among SHV ESBLs resulting in
amino acid insertions (Arpin et al., 2001; Ramdani-Bouguessa
et al., 2011) or deletions (Prinarakis et al., 1996). However,
their role in the rising of the extended-spectrum phenotype
remains unclear. SHV ESBL variants falling in this category
are: (i) SHV-9, with the deletion of Gly54 (Prinarakis et al.,
1996); (ii) SHV-16, with a 5-amino acid sequence duplication
(Asp163aArgGluTrpGluThr-Asp163bArgGluTrpGluThr) of the
amino acids between 163 and 167, including Glu166 in the
 loop (Arpin et al., 2001); (iii) SHV-100, with a 13-amino
acid insertion (SerGluSerGlnLeuSerGlyArgValGlyMetIleGlu)
between amino acids 35 and 36 (Ramdani-Bouguessa et al.,
2011); and (iv) SHV-183, with an Ala insertion between amino
acids 186 and 187 (http://www.lahey.org/studies). Of note, the
duplication observed in SHV-16 was shown to increase the
conformational flexibility of the catalytic region facilitating
the access of bulkier cephalosporins, such as ceftazidime, but
resulted in enzymatic instability (Arpin et al., 2001). This finding
could explain the low incidence of frame shift mutations among
extended-spectrum SHV β-lactamases, due to a deleterious effect
on the enzymes.
Overall, the available SHV ESBL kinetic parameters show
that most of the substitutions lead to more efficient hydrolysis
of oxyimino-β-lactams than penicillins, as depicted by the
low Kcat values for penicillins (Table 3). While they retain
their ability to hydrolyze penicillins, they are not catalytically
so efficient compared to SHV-1 (Bush and Singer, 1989)
and this is due to the decreased strength of the crucial
hydrogen-bonding network needed for penicillin catalysis
(turnover). As a consequence, since β-lactam inhibitors
(clavulanic acid, sulbactam, and tazobactam) are structurally
very similar to penicillin substrates, SHV ESBLs also exhibit
increased susceptibility to β-lactam inhibitors compared
to SHV-1 (Table 3) leading to less inhibitor required for
inactivation (lower Ki and IC50s; Tzouvelekis and Bonomo,
1999).
DETECTION
There are at least 46 known SHV-ESBL genes together with
more than 150 non-ESBL or unclassified alleles to date (http://
www.lahey.org/studies/). Accurate identification of these variants
is essential for surveillance and for epidemiological studies
of transmission mode, particularly in clinical setting, where
appropriate antimicrobial therapy is critical.
A panel of different phenotypic confirmatory tests is available
to determine the presence of extended-spectrum β-lactamases,
including SHV-variants: minimum inhibitory concentration
(MIC) determination of β-lactam with and without clavulanic
acid, double disk synergy test (DDST), inhibitor potentiated
disk diffusion test (IPDDT), three-dimensional test (TDT)
and commercially available methods (Etest for ESBLs, Vitek
ESBL cards, MicroScan panels, and BD Phoenix Automated
Microbiology System (Bradford, 2001; Paterson and Bonomo,
2005). Standard microbiological procedures can take up to
several days for culture, isolation and characterization and many
comparative studies have shown that PCR-based methods have
higher sensitivity (Bedenic et al., 2001, 2007; Singh et al., 2012),
mostly due to variable levels of gene expression. Therefore,
PCR and nucleotide sequence analysis (Stürenburg et al.,
2003), together with various PCR-based methods, remain the
gold standard for extended-spectrum β-lactamase SHV-variants
identification.
Chanawong and colleagues developed a PCR-restriction
fragment length polymorphism (PCR-RFLP) method to allow
the identification of new SHV β-lactamases variants through
detection of known mutations that alter recognition sites of
restriction endonucleases (Chanawong et al., 2000). PCR-RFLP
complements pre-existing PCR-single strand conformational
polymorphism (PCR-SSCP) limited by partial gene amplification,
thus missing potential mutation sites (M’Zali et al., 1998).
PCR-RFLP can also be used in combination with restriction
site insertion-PCR (RSI-PCR), a method based on primers
mismatches, allowing the unambiguous identification of up
to 27 SHV variants by point mutation (Chanawong et al.,
2001a). Fluorescently labeled hybridization probes followed
by melting curve analysis can also be used to discriminate
between ESBL and non-ESBL blaSHV genes (Randegger and
Hächler, 2001). This method, termed the SHV melting curve
mutation detection method, is also able to categorize SHV
ESBL producers into phenotypically relevant subgroups: (i)
weak ceftazidime resistance (SHV-6 and SHV-8); (ii) significant
resistance to cefotaxime and ceftriaxone and moderate resistance
to ceftazidime (SHV-2, SHV-2a, and SHV-3); and (iii), most
effective against all expanded-spectrum cephalosporins (SHV-
4, SHV-5, SHV-9, and SHV-12). Combined systems can also
be developed ad hoc to rapidly screen local epidemiological
settings (Chia et al., 2005). A modified SHV melting-curve
mutation detection method able to distinguish between prevalent
Taiwanese blaSHV genes (SHV-1, SHV-2, SHV-2a, SHV-5, SHV-
11, and SHV-12) was combined with a multiplex PCR to
identify different β-lactamases genes (blaSHV, blaCTX-M-3-like,
and blaCTX-M-14). The design of this method can be easily
adapted to other geographic areas where different ESBLs
are prevalent. Multiplex real-time PCR assays for the fast
detection of extended-spectrum β-lactamase and carbapenemase
genes were developed with differential melting curves able to
recognize up to 120 different SHV allelic variants (Singh et al.,
2016).
New techniques for ESBL detection are employed alongside
PCR-based methods these days. Loop-mediated isothermal
amplification (LAMP) was applied to detect SHV- and other
ESBL-producing bacteria in meat and proved to be more
specific and sensitive than MacConkey agar or cefpodoxime disc
methods (Anjum et al., 2013). Commercial DNA microarrays
are also proving themselves to be accurate, with sensitivity
and specificity values for ESBL detection being high. Up to
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53 SHV-variants can be covered on a same array (Leinberger
et al., 2010), but on the other hand some alleles may fail to
be detected (i.e., SHV-12), as previously reported (Stuart et al.,
2012). Because arrays have major limitations to detect novel
genes or variants, PCR and sequencing remains essential. Matrix-
assisted laser desorption ionization-time of flight (MALDI-
TOF) mass spectrometry (MS) is routinely used for bacteria
identification and has been recently applied to detect ESBL-
producing Enterobacteriaceae from positive blood cultures in
clinical practice (Jung et al., 2014; Oviaño et al., 2014).
Although, this methodology has yet to be fully validated,
preliminary results show 99% sensitivity and 100% specificity,
and denote a novel approach to categorize bacteria as ESBL
producers.
Pyrosequencing combines standard PCR and sequencing
by synthesis to rapidly determine the sequence of a target
DNA region; it has been extensively used for the detection of
bacterial resistance genes and bacterial community composition
(Tang et al., 2016; Tian et al., 2016). This technique has
been used to perform mutation analysis of blaSHV to resolve
heterogeneous sequences in clinical isolates of K. pneumoniae
containing more than one SHV variant (Haanperä et al.,
2008). An alternative protocol for pyrosequencing is the single-
nucleotide polymorphism (SNP), ideal for the sequencing of
mixed templates and determination of SNPs at the position
of interest. This protocol has been applied to discriminate
between eight blaSHV variants from clinical isolates of E. coli
and K. pneumoniae, reporting great reproducibility and ability to
discriminate between sequences (Jones et al., 2009). A multiplex
pyrosequencing assay coupled with qPCR amplification has
also been recently developed to enable rapid and accurate
detection of blaSHV and blaTEM -producing Enterobacteriaceae
(Deccache et al., 2015). Overall, pyrosequencing can be a useful
epidemiological tool for the exact identification of blaSHV as a
prerequisite for analyzing the spread of certain SHV variants.
Finally, the advent of whole genome sequencing (WGS)
has taken differentiation of bacterial strains and identification
of the associated antibiotic resistance gene cargo to another
level. Aside from the phylogenetic analysis that WGS provides,
the complete resistome of a strain can be unraveled as
well as its mobilome, i.e., the mobile genetic elements that
are associated with antibiotic resistance diffusion. Only this
information can provide us with full understanding of complex
genomic structures as observed, for example, in clinical K.
pneumoniae genomes carrying (i) nineteen antibiotic resistance
genes including blaOXA-1 and blaSHV-28 in the chromosome,
blaNDM-1 in a plasmid, and blaOXA-232 in a second plasmid
(Kwon et al., 2016); (ii) β-lactamase genes blaKPC−2, blaSHV-11,
blaTEM−169, and blaOXA-9, together with aac(6′-)Ib, aadA2,
and aph(3′-)Ia as aminoglycoside resistance encoding genes,
mph(A) for macrolides, oqxA and oqxB for quinolone, catA1
for phenicol, sul1 for sulfonamide, and dfrA12 for trimethoprim
(Lee et al., 2014); or (iii) six different plasmids, adding up to
0.43 Mbp, coding for six β-lactamases (blaSHV-12, blaOXA-9,
blaTEM-1, blaCTX-M-2, and blaKPC−2), together with blaSHV-110
and adhesin-related gene clusters on the chromosome (Perreira
Ramos et al., 2014).
EXPANSION TOWARD NEW ECOLOGICAL
NICHES
Over the last years the presence of antibiotics as well as
antibiotic resistant bacteria has been shown outside the clinical
environment, including water, soil and, most notably, food
producing animals. When looking at SHV-variants distribution
it is evident that in recent years, as for most extended-spectrum
β-lactamases (Canton et al., 2012), their presence has been
confirmed in virtually all ecological niches (Supplementary Table
S1), making it more challenging to restrain antibiotic resistance
diffusion. The most representative cases and variants will be
discussed.
Aquatic Environment
In an effort to control the release of antibiotics and antibiotic
resistant bacteria in the environment, aquatic environments are
being investigated worldwide, whether they be natural, drinking
or wastewaters. The latter are particularly worrisome given the
high prevalence of blaSHV alleles, as observed in untreated
hospital wastewater in Australia (Gündogdu et al., 2013), their
possible association with determinants of quinolone and other β-
lactamase resistance (Calhau et al., 2015; Osinska et al., 2016),
and their relatively easy transmission to surface water through
waste water treatment plant discharges (Marti et al., 2013).
Studies showed that SHV types, together with CTX-M and OXA
genes can be significantly decreased by biological treatments such
as activated sludge processing and anaerobic digestion, although
not all can be effectively eliminated (Yi et al., 2015).
Urban waters are also exposed to relatively high population
densities and therefore are often unprotected from biological
contaminants, with people playing a crucial role in antibiotic
resistance dissemination in the environment. Unusual
finding of SHV-producing Stenotrophomonas maltophilia
in a swimming recreational Serbian lake and its transient
presence during summer months can be considered as a
proof of its anthropogenic origin, given its nature of emerging
nosocomial pathogen (Novovic et al., 2015). Similar conclusions
can be drawn for SHV-producing K. pneumoniae and E. cloacae
isolated from a Bangladeshi lake, which receives waste water
from surrounding residents, commercial buildings and clinics
in Dhaka city (Haque et al., 2014), as well as for artificial
water reservoirs in Poland (Wolny-Koladka and Lenart-Boron,
2016), or urban surface waters in Malaysia (Tissera and Lee,
2013). In recent surveillance studies of different rivers and
lakes in Switzerland, blaSHV-12-producing Enterobacteriaceae
were isolated only in 4% of the cases (Zurfluh et al., 2013),
although this variant is predominant in clinical Swiss isolates
(Nüesch-Inderbinen et al., 1997). blaSHV-12 was also detected in
Enterobacteriaceae from seawater, together with tet(A) and sul2
in Portugal (Alves et al., 2014), and plasmid-encoded together
with blaTEM-1 and/or blaCTX-M-1 in Croatia (Maravic et al.,
2015). Finally, data on ESBL-producing Enterobacteriaceae
isolated from drinking water is also increasing, reporting SHV
alleles in rural water reservoirs in China (Zhang et al., 2015), or
drinking water sources for First Nation communities in Canada
(Fernando et al., 2016).
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Food Producing Animals
Food producing animals have become subject of increasing
interest after several studies demonstrated that resistant strains
of animal origin can be associated to human infections, possibly
through the food chain (Hasman et al., 2005). Majority of
SHV variants in this reservoir belong to blaSHV-2, blaSHV-2a,
blaSHV-5, and blaSHV-12 (Supplementary Table S1) owing to their
successful association with conjugative plasmids (see Section
Plasmid epidemiology of blaSHV-2, blaSHV-2a, blaSHV-5, and
blaSHV-12).
Surveillance activities in healthy animals worldwide are
generating a tremendous amount of data on ESBL distribution.
Most SHV β-lactamase producers are E. coli from swine
and broiler fecal samples as observed in China (Tian et al.,
2012); in Spain, with blaSHV-2 associated with blaCTX-M-9 and
blaSHV-12 with blaCTX-M-1, in pigs and broilers respectively
(Blanc et al., 2006); in layers, cattle, and broilers but not in
swine in Japan (Hiki et al., 2013; Kameyama et al., 2013); and
in the Netherlands, where healthy broilers carried blaSHV-2
in combination with blaTEM-1 or blaTEM−135 (Dierikx et al.,
2010). Other Enterobacteriaceae like K. pneumoniae and
Citrobacter freundii were positive for blaSHV-2 or blaSHV-12
from poultry and swine, respectively (Machado et al.,
2008).
Finding ESBL producers in food producing animals is also
mirrored by positive food samples worldwide, mostly retail
chicken meat, as reported in Tunisia, with E. coli carrying
blaSHV-5 isolated from different butcheries, supermarkets, and
local markets (Jouini et al., 2013), or Salmonella enterica
carrying blaSHV-12 in Japan (Noda et al., 2015). The cross-
contamination between food producing animals and retail meat
has been internationally demonstrated due to the detection of
plasmid-borne SHV variants, such as blaSHV-2 and blaSHV-2a
from Canadian chicken meat and abattoir chicken cecum
(Pouget et al., 2013) or blaSHV-2 and blaTEM-1 in Japan
(Hiroi et al., 2011), presenting the potential for horizontal
transfer between Enterobacteriaceae as a high public health
concern.
SHV β-lactamase producing Enterobacteriaceae have been
detected also in diseased animals, as reported for septicemic
broilers due to avian pathogenic E. coli encoding a remarkable
array of antibiotic resistance genes (dfrA17-aadA5, blaTEM-1,
blaCTX-M-15, blaOXA-1, blaSHV-2, tet(A), tet(E), qnrB2, aac(6)-
Ib-cr) (Ahmed et al., 2013); for K. pneumoniae isolated
from bovine mastitis in the United Kingdom (Timofte et al.,
2014) and Egypt (Ahmed and Shimamoto, 2011); and for
multidrug resistant S. enterica serotypes Enteritidis and
Typhimurium isolated from diarrheic calves (Ahmed et al.,
2009).
Finally, blaSHV-27 is the only other SHV variant frequently
reported as chromosomally located in K. pneumoniae from
swine, in association with blaSHV-11 and blaCTX-M-1 in China
(Zou et al., 2011); in E. coli isolated from farmed fish
together with non ESBLs blaSHV-1, blaSHV-11, blaSHV-25, and
blaSHV-26 (Jiang et al., 2012); and in opportunistic pathogens
asymptomatically colonizing healthy milk cows (Hammad and
Shimamoto, 2011).
Wildlife, Companion Animals, and
Vegetables
ESBL diffusion has been studied extensively in
Enterobacteriaceae from humans and livestock, whereas
information on antibiotic resistance in the environment is still
limited. Yet, the dissemination success of blaSHV-12 is confirmed
by its introduction into the wildlife, notably in birds, as reported
in Spain (Alcalá et al., 2015), the Netherlands (Veldman et al.,
2013), Poland (Literak et al., 2010), and the Czech Republic
(Dolejská et al., 2009). This success is likely associated to
predominant avian clones and to efficient plasmids (Table 4,
Figure 3) of the IncN incompatibility group, described to be
more frequent in pathogenic than in commensal avian and
human E. coli strains (Johnson et al., 2007). blaSHV-5 was also
detected in E. coli from several birds of prey in Portugal, alone or
in associations with blaTEM−1b (Pinto et al., 2010).
Emergence of Enterobacteriaceae producing β-lactamases in
companion animals have been gradually reported, with CTX-
M enzymes being prevalent as observed in the human scenario
(Rubin and Pitout, 2014). Few studies, on both healthy and
diagnostic clinical canine and feline samples, report finding other
ESBL variants including blaSHV-3 in the USA (Shaheen et al.,
2011), blaSHV-2 in Mexico (Rocha-Gracia et al., 2015), blaSHV-12
in Italy and Poland (Carattoli et al., 2005b; Rzewuska et al.,
2015) and blaSHV-12 in association with blaOXA-48, blaCMY-2,
blaTEM-1, aac(6′)-Ib-cr, and qnrB2 in Germany (Stolle et al.,
2013).
Lastly, SHV variants have been detected in imported
vegetables in Switzerland together with blaSHV-12 for the first
time in the opportunistic foodborne pathogen Cronobacter
sakazakii whose potential to cause bacteremia and meningitis
is an actual concern (Zurfluh et al., 2015). Similar results were
observed in vegetables collected in South Korea (Kim et al., 2015),
salads in the Netherlands (Reuland et al., 2014), and Spain (Egea
et al., 2011), displaying a new route of introduction for ESBLs and
pathogenic Enterobacteriaceae.
PLASMID EPIDEMIOLOGY OF blaSHV-2,
blaSHV-2A, blaSHV-5, AND blaSHV-12
The role of plasmids in the successful spread of β–lactamase
genes has been extensively described (Carattoli, 2009, 2013) and,
among the SHV family, it finds its best examples in blaSHV-2,
blaSHV-2a, blaSHV-5, and blaSHV-12. Combination of these alleles
with different dissemination machineries has brought the
enzymes to reach diverse niches worldwide (Figure 2). Plasmids
belonging to seven replicon types (A/C, F, HI2, I1, L/M, N,
X3) have been shown to drive the epidemiology of these four
predominant SHV ESBLs, although their distribution varies on
the plasmid families (Table 4). Other rep families that have
been only incidentally associated with extended-spectrum SHV
β–lactamases include the ColE, K, P, and R (Table 4).
IncA/C
blaSHV-12 has been identified on mostly conjugative broad-host
range IncA/C plasmids in a variety of bacterial species, including
Frontiers in Microbiology | www.frontiersin.org 13 September 2016 | Volume 7 | Article 1374
Liakopoulos et al. SHV β-Lactamases
TABLE 4 | Plasmid epidemiology of SHV-type extended-spectrum β-lactamases.
Inc Plasmid blaSHV Other Antibiotic Bacterial Country References
Group Size (Kb)* allele§ Resistance Genes Species#
IncA/C ND (C) SHV-12 or SHV-2a ND E. coli (H) Tunisia Mnif et al., 2013




A. caviae (H) Italy Antonelli et al., 2016
150 (NC) SHV-12 (IS26) blaCTX-M-14, blaDHA−1 P. mirabilis (H) Korea Song et al., 2011
ND SHV-2, SHV-5 or
SHV-12
ND E. coli (H) France Marcadé et al., 2009




P. stuartii (H) Greece Giakkoupi et al., 2015
97–145 SHV-45 blaCTX-M-2; blaSHV-27 K. pneumoniae (H) Brazil Dropa et al., 2015
63.5–209 SHV-55 blaCTX-M-2; blaSHV-28 K. pneumoniae (H) Brazil Dropa et al., 2015
IncA/C-IncR 220 (C) SHV-5 blaVEB−1, blaVIM−1,
rmtB, aacA7, dfrA1,
aadA1
P. stuartii (H) Greece Oikonomou et al., 2016
IncF 125 SHV-5 (IS26) ND E. coli (H) Poland Zienkiewicz et al., 2013
IncFIA-FIB ND (C) SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
IncFIB ND SHV-12 sul3 E. coli (A) Italy Bortolaia et al., 2010
95–200 (C) SHV-2 aadA1 E. coli (A) Canada Pouget et al., 2013
>23 SHV-2 ND K. pneumoniae (H) China Wang et al., 2012
ND SHV-2 ND E. coli (H) France Marcadé et al., 2009
ND (C) SHV-5 - E. coli (H) Uruguay
IncFIB10 ND SHV-12 (IS26) blaTEM-1 E. coli (H) UK Doumith et al., 2012
IncFIC ND SHV-5 aac(6′)-Ib’, aadA1 S. marcescens (H) Uruguay García-Fulgueiras et al., 2011
IncF-N ND SHV-2 aac(6′)-Ib’ K. pneumoniae (H) Uruguay García-Fulgueiras et al., 2011
IncFII ND SHV-2 or SHV-12 ND E. coli (H) France Marcadé et al., 2009
70–80 (C) SHV-2a (IS26) ND K. pneumoniae (H) Tunisia Elhani et al., 2010
100 (C) SHV-128 (IS26) ND E. cloacae (H) Tunisia Bourouis et al., 2015
IncFII-FIA ND (C) SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
IncFII-FIA-
FIB
ND (C) SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
IncFII-FIB ND SHV-2 ND E. coli (H) France Marcadé et al., 2009
ND (C) SHV-2a ND E. coli (H) Tunisia Mnif et al., 2013
IncFIIk1 200–220 SHV-2, SHV-55 or
SHV-106
ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
IncFIIk5 220 SHV-55 ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
IncHI2 ND (C) SHV-2a or SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
95 (C) SHV-12 (IS26) ND K. pneumoniae (H) Tunisia Elhani et al., 2010
310 (C) SHV-12 qnrB2, blaTEM-1, sul1,
dfrA19, tet(D), strA, strB,
aac(60)-1b
S. Senftenberg (H) Netherlands Veldman et al., 2010
200 (NC) SHV-12 tet(D) S. Concord (H) Netherlands Veldman et al., 2010
(Continued)
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TABLE 4 | Continued
Inc Plasmid blaSHV Other Antibiotic Bacterial Country References
Group Size (Kb)* allele§ Resistance Genes Species#
290 (C) SHV-12 qnrB2, blaTEM−1, sul1,
sul2, dfrA19, tet(D), strA,
strB,
S. Concord (H) Netherlands Veldman et al., 2010
180, 350, 380 SHV-12 ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
400 SHV-12 ND E. cloacae (H) Portugal Rodrigues et al., 2014
320 (C) SHV-12 qnrB2, strA/B, tet(D),
clmA, sul1
S. Bredeney (H) Spain Herrera-Leon et al., 2011
ND (C) SHV-12 (IS26) blaCTX-M-14 E. cloacae (H) Taiwan Chen C. M. et al., 2015
ND (C) SHV-12 (IS26) blaCTX-M-3 E. cloacae(H) Taiwan Chen C. M. et al., 2015
IncHI2 (ST1) 300 (C) SHV-2 ND S. Agona or
Keurmassar (H)
Senegal Harrois et al., 2014
IncI1 ND (C) SHV-12 ND E. coli (H) Bulgaria Markovska et al., 2014
ND SHV-12 ND E. coli (H) France Marcadé et al., 2009
ND SHV-12 sul3 E. coli (A) Italy Bortolaia et al., 2010
19 (C) SHV-12 – E. coli (A) Italy Bortolaia et al., 2011
340 (C) SHV-12 ND S. Concord (H) Norway
(Ethiopia)
Fabre et al., 2009
95 (C) SHV-12 – E. coli (A) Poland Literak et al., 2010
10 (NC) SHV-12 – S. enteritidis (H) Spain de Toro et al., 2013




Spain Tato et al., 2007
ND (C) SHV-12 (IS26) blaCTX-M-3 E. cloacae (H) Taiwan Chen C. M. et al., 2015
95–200 (C) SHV-2 aadA1 E. coli, S.
Heidelberg (A)
Canada Pouget et al., 2013
95–200 (C) SHV-2 – E. coli (A) Canada Pouget et al., 2013
95–200 (C) SHV-2a aadA1, dfrA1 E. coli, S. Kiambu
(A)
Canada Pouget et al., 2013
95–200 (C) SHV-2a aadA1 E. coli (A) Canada Pouget et al., 2013
IncI1 (ST26) ND SHV-12 ND E. coli (H) Italy Accogli et al., 2013
ND SHV-12 (IS26) ND E. coli (A) Portugal Jones-Dias et al., 2016
IncI1 (ST27,
CC26)
115 (C) SHV-2 aadA2 S. Livingstone (H) Spain de Toro et al., 2013
IncI1
(ST29/CC26)
ND (C) SHV-12 (IS26) ND E. coli (E) Portugal Jones-Dias et al., 2016
IncI1 (ST3) ND SHV-12 ND E. coli (A) Italy Accogli et al., 2013
104 (C) SHV-12 - E. coli (A) Italy Bortolaia et al., 2011
IncK ND (NC) SHV-12 ND K. pneumoniae (A) England Timofte et al., 2014
155 SHV-2 – E. coli (A) Netherlands Dierikx et al., 2010
IncL/M ND (C) SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
65 SHV-12 blaKPC−2, rmtB K. pneumoniae (H) China Liu et al., 2015
65 SHV-2 ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
ND (C) SHV-2a ND E. coli (H) Tunisia Mnif et al., 2013
60–70 (C) SHV-2a (IS26) ND K. pneumoniae (H) Tunisia Elhani et al., 2010
ND (C) SHV-5 (IS26) aacA4, aacC1, aadA1,
sul1
S. Typhimurium (H) Italy Villa et al., 2000
90 (C) SHV-5 tet(A), aadA1, aacC1,
aacA4, dfrA1
K. oxytoca (H) USA Preston et al., 2014
(Continued)
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TABLE 4 | Continued
Inc Plasmid blaSHV Other Antibiotic Bacterial Country References
Group Size (Kb)* allele§ Resistance Genes Species#
IncN ND (C) SHV-12 ND E. coli (H) Tunisia Mnif et al., 2013
ND (C) SHV-12 ND K. pneumoniae (H) Bulgaria Markovska et al., 2014
50 SHV-12 blaVIM−1, qnrS K. pneumoniae, E.
coli (H)
Norway Naseer et al., 2012
50 (C) SHV-12 blaVIM−1, qnrS K. pneumoniae (H) Norway Samuelsen et al., 2011
>23 SHV-2 (IS26) ND K. pneumoniae (H) China Wang et al., 2012
ND (C) SHV-2a ND E. coli (H) Tunisia Mnif et al., 2013
IncN (ST1) ND SHV-12 aadA2 E. coli (H) Netherlands Dierikx et al., 2013
IncN (ST16) 50 (C) SHV-2 ND S. Miami (U) Senegal Harrois et al., 2014
IncP ND (C) SHV-12 (IS26) – E. cloacae (H) Taiwan Chen C. M. et al., 2015
95–200 (C) SHV-2a aadA1, dfrA1 E. coli (A) Canada Pouget et al., 2013
IncX3 50 (C) SHV-12 blaKPC−2 K. pneumoniae (H) Australia Partridge et al., 2015
54 (C) SHV-12 blaNDM-1 K. pneumoniae (H) China Wang et al., 2014
54 (C) SHV-12 (IS26) blaNDM-1 K. pneumoniae, C.
freundii, E.
aerogenes, E.
cloacae, E. coli (H)
China Ho et al., 2012
60 (C) SHV-12 blaNDM-1, blaTEM-1 E. coli (H) China Huang et al., 2016
60 (C) SHV-12 blaNDM-1 E. coli (H) China Huang et al., 2016
54 (C) SHV-12 (IS26) blaNDM-1 E. coli (H) China Feng et al., 2015
54 (C) SHV-12 (IS26) blaNDM−1 C. freundii (H) China Du et al., 2013








53 SHV-12 (IS26) blaKPC−2 K. pneumoniae (H) France Kassis-Chikhani et al., 2013
50 (C) SHV-12 blaNDM-1 E. cloacae (H) UAE Sonnevend et al., 2013
50 (C) SHV-12 blaNDM-1 E. coli (H) UAE Sonnevend et al., 2013
50 (C) SHV-12 blaNDM-1 C. freundii (H) UAE Sonnevend et al., 2013
43 (C) SHV-12 (IS26) - E. cloacae (H) USA Hargreaves et al., 2015
IncX3-N 80 SHV-12 blaTEM-1, qnrS1 E. coli (A) Germany Dobiasova and Dolejska,
2016
ColETp 10 (NC) SHV-12 qnrS1 S. Typhimurium (H) Spain Herrera-Leon et al., 2011
R 70 SHV-12 ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
R+IncFIIk1 300 SHV-2 ND K. pneumoniae (H) Portugal Rodrigues et al., 2014
Untypable 90–140 (C) SHV-12 (IS26) ND K. pneumoniae (H) Tunisia Elhani et al., 2010
ND SHV-12 (IS26) - E. coli (H) UK Doumith et al., 2012
ND SHV-12 (IS26) blaTEM−1 E. coli (H) UK Doumith et al., 2012
ND SHV-12 (IS26) blaTEM-1, blaOXA-1,
qnrS1
E. coli (H) UK Doumith et al., 2012
50 (C) SHV-12 blaNDM-1 K. pneumoniae (H) UAE Sonnevend et al., 2013
*C, conjugative; NC, non-conjugative; when blank is because not determined.
§ When present, IS26 is indicated in parenthesis.
#H, human; A, animal (mostly poultry, turkey and broilers; check reference for full description); E, environment. ND, not determined.
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FIGURE 3 | Schematic representation of blaSHV genetic surroundings and IS26 association. Common occurring features are color coded. Map is not to
scale. References: IncN (Wang et al., 2012); IncA/C (Giakkoupi et al., 2015); IncL/M (Preston et al., 2014); IncHI2, IncI1, IncP (Chen C. M. et al., 2015); IncX3 (Ho
et al., 2012; Du et al., 2013; Kassis-Chikhani et al., 2013; Feng et al., 2015).
E. coli, Proteus mirabilis and Aeromonas caviae, isolated from
clinical samples in Tunisia, France, Korea and Italy (Marcadé
et al., 2009; Song et al., 2011; Mnif et al., 2013; Antonelli et al.,
2016). E. coli isolates recovered from clinical specimens encoding
blaSHV-2, blaSHV-2a, and blaSHV-5 have been also identified in
Tunisia and France (Marcadé et al., 2009; Mnif et al., 2013),
whereas Providencia stuartii isolates encoding blaSHV-5 on either
IncA/C or multireplicon IncA/C-R plasmids have been reported
from different outbreaks in Greece (Giakkoupi et al., 2015;
Oikonomou et al., 2016). Interestingly, these IncA/C plasmids
(130–220 Kb) often carried multiple resistance genes, conferring
multidrug resistant phenotypes (Giakkoupi et al., 2015; Antonelli
et al., 2016; Oikonomou et al., 2016), resulting in the proliferation
of the SHV ESBLs by co-selection.
IncF
Plasmids belonging to the narrow-host range IncF group,
including plasmids with fused replicons, have been reported
to accommodate blaSHV-12 among clinical E. coli isolates from
France (IncFII), Tunisia (IncFIA-FIB, IncFII-FIA, IncFII-FIA-
FIB) and United Kingdom (IncFIB), but also among food-
producing animals from Italy (IncFIB) (Marcadé et al., 2009;
Bortolaia et al., 2010; Doumith et al., 2012; Mnif et al., 2013). IncF
plasmids account for the dissemination of blaSHV-2 gene among
E. coli from both clinical specimens in France (IncFIB, IncFII,
IncFII-FIB) and food-producing animals (avian and porcine
sources) in Canada (IncFIB), as well as in clinical K. pneumoniae
isolates belonging to ST654 and ST15 from China (IncFIB) and
Portugal (IncFII), respectively (Marcadé et al., 2009; Wang et al.,
2012; Pouget et al., 2013; Rodrigues et al., 2014). Finally, clinical
E. coli and K. pneumoniae from Tunisia were found to encode
blaSHV-2a (Elhani et al., 2010; Mnif et al., 2013), clinical E. coli
from Poland encoded blaSHV-5 on IncF plasmids, as well as
clinical K. pneumoniae and Serratia marcescens from Uruguay
(García-Fulgueiras et al., 2011; Zienkiewicz et al., 2013), whereas
the same plasmids have been associated with less prevalent SHV
ESBLs (blaSHV-55 and blaSHV-106) in clinical K. pneumoniae
isolates from Portugal (Rodrigues et al., 2014).
IncHI2
In contrast with the IncA/C and IncF plasmids, the broad-host
range IncHI2 group is responsible mainly for the dissemination
of blaSHV-12, although this group has been found incidentally
to also accommodate blaSHV-2a (Mnif et al., 2013). Plasmids of
this group varying in sizes (95–400 Kb) have been reported to
encode blaSHV-12 in various bacterial species, such as E. coli, K.
pneumoniae, E. cloacae, and at least three S. enterica serotypes
(Bredeney, Concord, and Senftenberg) from human specimens
with diverse geographical origin (Netherlands, Portugal, Spain,
Taiwan, Tunisia; Elhani et al., 2010; Veldman et al., 2010;
Herrera-Leon et al., 2011; Mnif et al., 2013; Rodrigues et al., 2014;
Chen C. M. et al., 2015). Apart from blaSHV-12, some of these
conjugative plasmids have been reported to co-encode for other
resistance genes, including additional SHV ESBLs (blaCTX-M-3,
blaCTX-M-14; Veldman et al., 2010; Chen C. M. et al., 2015).
IncI1
The IncI1 group, consisting of narrow-host range mostly
conjugative plasmids, ranks amongst the top facilitators of
blaSHV-2, blaSHV-2a, and blaSHV-12 genes. The range of bacterial
species they have encountered is limited to E. coli,K. pneumoniae,
E. cloacae, and the S. enterica serotypes Concord, Enteritidis,
Heidelberg and Kiambu. Nevertheless, IncI1 plasmids (19–340
Kb) occur in very diverse settings: blaSHV-2- and blaSHV-12-
encoding isolates from human infections (Bulgaria, France, Italy,
Spain, Taiwan; Tato et al., 2007; Marcadé et al., 2009; Accogli
et al., 2013; de Toro et al., 2013; Markovska et al., 2014; Chen
C. M. et al., 2015) and colonization (Ethiopia) (Fabre et al.,
2009); blaSHV-2-, blaSHV-2a–, and blaSHV-12-encoding isolates
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from poultry (Canada, Italy, Portugal; Bortolaia et al., 2010, 2011;
Accogli et al., 2013; Pouget et al., 2013; Jones-Dias et al., 2015),
blaSHV-2- and blaSHV-2a-encoding isolates from pigs (Canada)
(Pouget et al., 2013); blaSHV-12-encoding isolates from aquatic
birds (Poland) (Literak et al., 2010); and blaSHV-12-encoding
isolates from farming soil (Portugal) (Jones-Dias et al., 2016).
Remarkably, blaSHV-12 on IncI1 plasmids belonging to pST26
have been identified among E. coli isolates of human and animal
origin (Accogli et al., 2013; Jones-Dias et al., 2015), indicating the
potential transmission of these blaSHV-12-encoding vehicles from
human to animals and/or vice versa.
IncL/M and IncN
The broad-host range IncL/M and IncN plasmids contribute
to a lesser extent to the epidemiology of blaSHV-2, blaSHV-2a,
blaSHV-5, and blaSHV-12 than the above-mentioned families.
IncL/M plasmids (60–90 Kb) carrying SHV ESBL genes have
been reported only among E. coli,K. pneumoniae, K. oxytoca, and
S. enterica serotype Typhimurium of human origin in Portugal
(blaSHV-2), Tunisia (blaSHV-2a, blaSHV-12), Italy (blaSHV-5), USA
(blaSHV-5), and recently in China (blaSHV-12) (Villa et al., 2000;
Elhani et al., 2010; Mnif et al., 2013; Preston et al., 2014;
Rodrigues et al., 2014; Liu et al., 2015). The same bacterial species
mostly from human sources carry IncN plasmids (∼50Kb)
encoding blaSHV-2 (China, Senegal), blaSHV-2a (Tunisia) or
blaSHV-12 (Bulgaria, Netherlands, Norway, Tunisia; Samuelsen
et al., 2011; Naseer et al., 2012; Wang et al., 2012; Dierikx
et al., 2013; Mnif et al., 2013; Harrois et al., 2014; Markovska
et al., 2014). Interestingly, the presence of IncN (pST1) plasmids
encoding blaSHV-12 has been reported among E. coli from
human and animal sources (Dierikx et al., 2013), mirroring the
situation for IncI1 plasmids and underscoring the contribution
of this plasmid family in the transmission of blaSHV-12 within or
between these niches.
IncX3
The IncX3 plasmid subgroup consists of narrow-host range
plasmids and plays an important role in the exclusive
dissemination of blaSHV-12. Conjugative plasmids (40–60 Kb) of
this subgroup have been identified in diverse bacterial species
(E. coli, K. pneumoniae, C. freundii, E. aerogenes, E. cloacae),
sources (human, animal, environment) and geographical
areas (Australia, China, Czech Republic, France, United Arab
Emirates, US; Ho et al., 2012; Du et al., 2013; Kassis-Chikhani
et al., 2013; Sonnevend et al., 2013; Wang et al., 2014; Feng et al.,
2015; Hargreaves et al., 2015; Partridge et al., 2015; Dobiasova
and Dolejska, 2016; Huang et al., 2016). Interestingly, the
majority of these plasmids appear to co-harbor carbapenemase
genes (blaKPC-2, blaNDM-1), whereas the co-localization of SHV
ESBL and carbapenemase genes was reported only on IncA/C or
IncA/C-R (blaVIM−1), IncL/M (blaKPC−2), and IncN (blaVIM−1)
plasmids (Samuelsen et al., 2011; Naseer et al., 2012; Giakkoupi
et al., 2015; Oikonomou et al., 2016), enhancing the plasmid
potential maintenance among bacterial populations and the
subsequent preservation and dissemination of the SHV ESBL
genes.
Miscellaneous Plasmids
blaSHV-12 has been incidentally found on: (i) a ColE plasmid from
S. enterica serotype Typhimurium DT104b in Spain (Herrera-
Leon et al., 2011); (ii) an IncK plasmid from K. pneumoniae
in the United Kingdom (Timofte et al., 2014); (iii) an IncP
plasmid from E. cloacae in Taiwan (Chen C. M. et al., 2015);
and (iv) a plasmid assigned to the R replicon type from K.
pneumoniae in Portugal (Rodrigues et al., 2014). E. coli and K.
pneumoniae encoding blaSHV-2 on IncK plasmids were recovered
from animal and human sources in the Netherlands and in
Uruguay, respectively (Dierikx et al., 2010; García-Fulgueiras
et al., 2011). IncP plasmids encoding blaSHV-2a from animals in
Canada and blaSHV-5 from human in Uruguay have also been
reported (García-Fulgueiras et al., 2011; Pouget et al., 2013).
Finally, a number of reports highlight the presence of blaSHV-12
on mostly conjugative non-typeable plasmids, according to the
PCR-based replicon-typing scheme (Carattoli et al., 2005a).
These plasmids of human origin, varying between 50 and 140
Kb in size, were mostly detected among E. coli from the United
Kingdom (Doumith et al., 2012) andK. pneumoniae fromTunisia
(Elhani et al., 2010) and United Arab Emirates (Sonnevend et al.,
2013), underscoring that their dissemination is wider than we
know.
IS26 Role in blaSHV Mobilization
Analysis of the sequences bracketing several SHV ESBL
genes (blaSHV-2, blaSHV-2a, blaSHV-5, blaSHV-12, blaSHV-106,
and blaSHV-134) among Gram-negative bacteria, including
Enterobacteriaceae and non-fermenters, revealed that these β-
lactamase genes are mostly associated with the IS26 element
(Table 4, Supplementary Table S1). Beside SHV ESBLs, this
member of the IS6 insertion sequence family (Mahillon and
Chandler, 1998), has been associated with a plethora of resistance
genes (Allard et al., 1993; Miriagou et al., 2005; Post and
Hall, 2009; Cain et al., 2010; Hordijk et al., 2011) and has
been found to contribute to their expression by supplying a
promoter -35 box that can be coupled with a -10 box in
the adjacent DNA (Lee et al., 1990; Cain and Hall, 2011). In
contrast to other insertions sequences, it has been suggested
that IS26 transposes preferentially within plasmids rather than
into the chromosome (He et al., 2015), possibly explaining the
linkage of IS26 and the four predominant SHV ESBL genes
with IncA/C (blaSHV-5, blaSHV-12), IncF (blaSHV-2a, blaSHV-5,
blaSHV-12), IncHI2 (blaSHV-12), IncI1 (blaSHV-12), IncL/M
(blaSHV-2a, blaSHV-5), IncN (blaSHV-2), IncP (blaSHV-12), IncX3
(blaSHV-12), and non-typeable (blaSHV-12) plasmids (Table 4).
Similarly to most antibiotic resistance genes, IS26-mediated
mobilization of SHV ESBL genes on conjugative plasmids
facilitated their subsequent intra- and inter-species dissemination
(Table 4). Available sequences of transposons flanked by copies
of intact and/or truncated IS26 elements (Figure 3) and coding
for SHV ESBL genes show the presence of other co-linear genes
originating from the chromosome of K. pneumoniae (i.e., fucA,
ygbI, ygbK, ygbJ, ygbM, deoR; Ho et al., 2012; Wang et al., 2012;
Du et al., 2013; Kassis-Chikhani et al., 2013; Preston et al., 2014;
Chen C. M. et al., 2015; Feng et al., 2015; Giakkoupi et al., 2015),
likely underscoring the involvement of IS26 in the mobilization
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of blaSHV from the chromosome of K. pneumoniae, as previously
suggested (Haeggman et al., 1997).
OUTSIDE OF THE
ENTEROBACTERIACEAE AND A FEW
PECULIAR SHV ESBLS
SHV β–lactamases have virtually invaded all human,
environmental and animal sceneries, mostly associated to
Enterobacteriaceae. In recent years, the first reports of alternative
bacterial hosts have been described, notably in Aeromonads,
ubiquitous in aquatic habitats and occasionally able to cause
human infections. blaSHV-12 was detected, in association
with blaFOX-2 and blaCTX-M-15, on the chromosome of the
foodborne pathogens A. caviae and Aeromonas hydrophila from
wild-growing mussels from Croatia (Maravic´ et al., 2013). The
first identification of plasmid-encoded SHV-12, together with
VIM-1, occurred in clinical A. caviae accountable for a newborn
bloodstream infection (Antonelli et al., 2016). The coproduction
of these enzymes highlights the potential risks for public health
and the role of Aeromonads as reservoirs and dissemination
tools of resistance determinants in both environmental and
clinical settings.
Occasionally, SHV ESBL-producing Pseudomonas aeruginosa
can be detected in nosocomial settings and can pose a serious
threat as healthcare-associated infection in many regions of
the world. blaSHV-2a was first identified on the chromosome
of a 1995 clinical P. aeruginosa strain, with high sequence
homology to plasmid pMPA2a from K. pneumoniae indicating a
likely enterobacterial gene origin (Naas et al., 1999). Subsequent
studies demonstrated the insertion of blaSHV alleles into P.
aeruginosa chromosome: blaSHV in China (Chen Z. et al., 2015)
and Iran (Shahcheraghi et al., 2009); blaSHV-5 (Poirel et al.,
2004) and blaSHV-12 (Neonakis et al., 2003) in Greece; and
blaSHV-2a in Tunisia (Mansour et al., 2009) and France (Hocquet
et al., 2010; Jeannot et al., 2013). The role of IS26 in the
mobilization of blaSHV-12 was demonstrated by the chromosomal
insertion of an IS26 composite transposon (>24 kb) thanks
to the co-mobilization of antibiotic resistance aac(6′)-Ib,
which confers amikacin resistance, likely occurred during the
clinical course of a burn infection, immediately after amikacin
administration (Uemura et al., 2010). blaSHV-5, blaSHV-11,
blaSHV-12 were also detected in different combinations, together
with blaTEM-1b, on various plasmids in Thailand (Chanawong
et al., 2001b).
Finally, one of the most effective associations outside
of the Enterobacteriaceae is with Acinetobacter baumannii,
contributing to the worrisome spread of ESBL-producing strains
especially in clinical outbreaks (Blackwell et al., 2016). Plasmid
transfer from nosocomial SHV-encoding Enterobacteriaceae
seems to be responsible for this phenomenon, as observed for
SHV-12 in the Netherlands (Naiemi et al., 2005), or SHV-5 in
the USA, a country where this variant is the most prevalent ESBL
gene in Enterobacteriaceae (Naas et al., 2007).
Among all ESBL SHV β-lactamases, few enzymes deserve
special consideration because of their unique enzymatic features.
SHV-38 is a unique allelic variant of the SHV family to have an
expanded-spectrum to carbapenems. It was first described in K.
pneumoniae from France (Poirel et al., 2003) and it holds a point
mutation (Ala146Val) compared to the chromosome-encoded
SHV-1. Among all 46 available SHV ESBL variants, only SHV-
38 possess the Ala146Val substitution (Table 2), likely inducing
subtle structural conformational changes favoring imipenem
but not meropenem hydrolysis (Walther-Rasmussen and Høiby,
2007).
SHV-129 is a novel clinically acquired variant identified in
2012 from an Italian E. coli isolate (Table 1; Lascols et al., 2012)
and it represents an interesting example of enzyme evolution
due to antibiotic pressure. Alongside two well-known amino
acid substitutions (Gly238Ser, Glu240Lys), SHV-129 contains new
substitutions, Arg275Leu and Asn146Asp). The latter was recently
demonstrated to be the first global suppressor substitution
identified in the SHV β-lactamase family (Winkler and Bonomo,
2016), likely helping in protein stabilization and functionality,
as well as in the ability of the enzyme to acquire additional
substitutions. It is also proposed that due to the increasing clinical
use of cefepime, SHV-129 might have evolved from SHV-2 or
SHV-5 in an alternative conformation to expand its spectrum to
hydrolyze cefepime, as mirrored by the kinetic parameters of the
three enzymes (Table 3).
Finally, SHV-2 can be located on both chromosome and
self-transmissible plasmids (Table 4; Supplementary Table S1).
Association of blaSHV-2 with RCS47, a P1-like bacteriophage
that infects and lysogenizes E. coli and several other enteric
bacteria, was recently reported (Billard-Pomares et al., 2014).
blaSHV-2 is flanked by two IS26 elements that likely drove the
insertion in the phage backbone. The P1-like prophages were
found with high prevalence in natural E. coli of both animal and
human origin, including ESBL-producing isolates. This kind of
association was already reported for other β-lactamases (blaTEM,
blaCTX-M, and mecA) from river and urban sewage water (von
Wintersdorff et al., 2016), suggesting that bacteriophages might
play a wider role in favoring horizontal transfer of antibiotic
resistance determinants than initially thought (Muniesa et al.,
2013).
CONCLUDING REMARKS
Tzouvelekis and Bonomo suggested than “it will not be
surprising if (SHV) enzymes will continue to expand their
substrate spectrum as long as the current antibiotics, or novel
ones derived from the basic β-lactam structure, are used”
(Tzouvelekis and Bonomo, 1999). In the last two decades we
observed the appearance of multiple SHV-type variants, with few
ones significantly expanding their substrate. One exception is
represented by SHV-38, the only known SHV allelic variant able
to hydrolyze carbapenems (Poirel et al., 2003), a feature that has
not been associated with any TEM or CTX-M enzyme. In this
image resides the fate of SHV extended β-lactamases, unable to
undergo the dominant propagation observed, for instance, for the
CTX-M family but yet contributing to β-lactam resistance in a
not negligible way.
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The persistence of SHV enzymes in the bacterial community
might also be secured by co-selection with emerging resistance
genes. Association of blaSHV-12 with IncX3 plasmids carrying
carbapenemase genes blaKPC−2 and blaNDM has been observed
in recent years (Table 4) and it seems to be a phenomenon
occurring in clinical carbapenem-resistant Enterobacteriaceae
worldwide (Kassis-Chikhani et al., 2013; Sonnevend et al., 2013;
Partridge et al., 2015; Huang et al., 2016). As highlighted in
this review, the association of successful variants blaSHV-2,
blaSHV-2a, blaSHV-5, and blaSHV-12 with different families
of conjugative plasmids (IncA/C, IncF, IncHI2) might also
underlie the colonization of virtually all ecological niches
encompassing food producing animals, aquatic environment,
wildlife, companion animals, and vegetables. Plasmid mediated
transfer from nosocomial Enterobacteriaceae enabled SHV
dispersion toward alternative bacterial hosts such as the emerging
nosocomial pathogens of aquatic origin S. maltophilia and
A. caviae, or contributed to the worrisome spread of ESBL-
producing strains of A. baumannii and P. aeruginosa. Most
interestingly, the ubiquitous presence of SHV ESBL genes and
plasmids is suggestive for transmission in human, animals,
and the environment, most likely through the food chain,
highlighting the potential risks for public health and endorsing
a one health research approach.
Overall, SHV ESBL enzymes have kept a stable role in
antibiotic resistance over the years. Allele diversification is still
occurring, the latest variant being identified in E. cloacae in
2014 (blaSHV-183), and effective associations with new genetic
platforms are taking place helping expansion toward novel
bacterial hosts and reservoirs.
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